TrialEuropean journal of clinical pharmacology2006

Amodiaquine, its desethylated metabolite, or both, inhibit the metabolism of debrisoquine (CYP2D6) and losartan (CYP2C9) in vivo.

Agneta Wennerholm et al.PubMed ↗Publisher ↗

No numbers read from the abstract.